Intelligo

Private limited company · Oslo

DR.DROPIN AS

ActiveGeneral medical practice activities (86.210)

Founded
17 May 2017
Employees
45
Business address
Sørkedalsveien 8A, 0369 Oslo

The life line 2017–2026

Operating revenue per year, with recorded events above. As a table

Operating revenue 2025: NOK 140.0m.

  1. Kapital§ 14
  2. Gjennomføring av fusjon§ 14
  3. Managing director took office§ 07
  4. Chair took office§ 07
  5. Founded§ 16

Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.

In brief

DR.DROPIN AS is a private limited company in Oslo, founded in 2017, in the industry general medical practice activities. The chief executive is Kristoffer Ingebrigtsen, and the chair of the board is Martin Schütt. In 2025 the company had NOK 140.0m in operating revenue and a net profit of NOK −17.1m; the group had revenue of NOK 435.3m. The largest owner is ASKELADDEN & CO 1 AS with 18.7%.

Put together by Intelligo from the sections below; each figure stands with its source where it belongs.

Overview

§ 01 Latest changes

4 changes, latest 14 Oct 2026

  • Number of employees 44 → 45
  • Number of employees 45 → 44
  • Changed capital 13951255 → 14001701
  • Changed capital 1395125.5 → 1400170.1

Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →

Overview

§ 02 Worth knowing

2 points

  • NoteOperating loss three years running, 2023–2025
  • OKEquity ratio 76.6%, above the industry median

Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate

Overview

§ 03 Key figures

Revenue NOK 140.0m in 2025

Revenue

NOK 140.0m

+14.4% from 2024

20232025

Operating profit

NOK −25.4m

+45.3% from 2024

20232025

Net profit

NOK −17.1m

+48.8% from 2024

20232025

Equity

NOK 234.6m

−4.4% from 2024

20232025

Merger carried out 21 Dec 2024: the figures before and after are not the same business.

Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →

Finances

§ 04 Where the money comes from and goes

Financial year 2025

Of every krone of operating revenue in 2025:

  • Wages and social costs 57%
  • Depreciation 3%
  • Other operating costs 42%
  • Not specified in the source 16%

Costs exceeded revenue: the operating result was NOK −25.4m.

Source: the Register of Company Accounts via areg.no, read 15 Nov 2026

Finances

§ 05 Financial health

Equity ratio 76.6%

RevenueNOK 140.0m Operating margin−18.2% Equity ratio76.6% Revenue growth+14.4%
  • DR.DROPIN AS, 2025
  • Industry median, assumed: NOK 3.4m · 7.4% · 41.6% · +2.4%

Equity NOK 234.6m77% of the assets (NOK 306.5m)

Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 1,840 companies in 86.210 General medical practice activities, not stated by the source.

Finances

§ 06 Accounts

9 years, latest 2025

NOK 1,0002023–25202520242023
Operating revenue139,995122,389105,620
Operating profit−25,412−46,444−101,497
Profit before tax−22,850−42,335−96,772
Net profit−17,088−33,368−72,795
Total assets306,481288,458242,811
Equity234,615245,483222,504
Liabilities71,86642,97520,307

Source: the Register of Company Accounts, read 15 Nov 2026 · All 9 years →

Management and ownership

§ 07 Officers

9 officers now

The board: 7 members

Source: the Brønnøysund Register Centre, read 26 Aug 2026 · All 9 roles, former ones too →

Management and ownership

§ 08 Signature, procuration and authorisations

Daglig leder og styrets leder i fellesskap.

May sign for the company:

Daglig leder og styrets leder i fellesskap.

Procuration: none registered.

The board has 1 authorisation in force now: capital increase, until 19 Jun 2028.

The signature is word for word from the register. Source: the Register of Business Enterprises, read 2 Oct 2026

Management and ownership

§ 09 Owners

120 shareholders · largest 18.7%

OwnerShare
ASKELADDEN & CO 1 AS
18.7%
THE LIGHTHOUSE AS
9.7%
ANDENES VENTURES AS
8.4%
117 others63.1%

Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 120 owners →

Management and ownership

§ 10 Group

8 subsidiaries

DR.DROPIN AS parent company

The group 2025: operating revenue NOK 435.3m (+40.1%).

Share held. Source: the Tax Administration's shareholder register, fetched 31 Jul 2026 · The whole group →

Management and ownership

§ 11 Portfolio

Holds shares in 5 companies

Management and ownership

§ 12 Network

96 connections

  • Person
  • Company

6 people link DR.DROPIN AS to 84 other companies: Martin Schütt 37, Marianne Gaarder Amland 20, Martine Drageset 15, Kristoffer Ingebrigtsen 13, Geir Langfeldt Olsen 6 and Daniel Sørli 2.

Source: the Brønnøysund Register Centre, read 26 Aug 2026 · Explore the network →

Events and registers

§ 13 Events

72 since 2017

Events per year

20172026

  • Notices61
  • Register changes10
  • Tenders won1

Since 2017: 61 announcements, 10 register changes and 1 tender won. Most happened in 2023 and 2026.

Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 2 Nov 2026. Register changes are Intelligo's own observations. · All 72 events →

Events and registers

§ 14 Notices

61, latest 9 Sep 2026

  • Kapital
  • Vedtektsdato
  • Fullmakt kapitalforhøyelse

Source: The Brønnøysund Register Centre's announcements ↗, read 2 Nov 2026 · All 61 →

Events and registers

§ 15 Charges

Not fetched yet

Events and registers

§ 16 Other registers

Found in 3 of 7

  • The Central Coordinating RegisterRegistered 19 Jun 2017
  • VATRegistered
  • The Register of Business EnterprisesRegistered 19 Jun 2017
  • The Cleaning RegisterNot registered
  • The Register of Staffing AgenciesNot registered
  • Smiley scheme, the Norwegian Food Safety AuthorityNot registered
  • The Financial Supervisory Authority's licence registerNot registered

Purpose: Levere gode helsetjenester til alle, med god tilgjengelighet og pris.

Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026

Market

§ 17 Tenders

1 tender

  • 2024
  • Won
  • Lost
AwardedContractBuyerOutcome
Jun 2024Bedriftshelsetjeneste - KontraktstildelingNORGES BANKWon

Source: Doffin and TED, read 10 Jul 2026. · All 1 tenders →

Market

§ 18 Vacancies

None registered

No vacancies.No open ads at NAV. Checked 15 Nov 2026.

Market

§ 19 Competitors

Industry code 86.210

The companies most like it:

Compare them

The selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →

Last

§ 20 Questions and answers

7 questions

  • Who is the chief executive of DR.DROPIN AS?
    Kristoffer Ingebrigtsen, since 2023. § 07
  • Who owns DR.DROPIN AS?
    120 shareholders. The largest is ASKELADDEN & CO 1 AS with 18.7%, THE LIGHTHOUSE AS with 9.7% and ANDENES VENTURES AS with 8.4%. § 09
  • What was the revenue in 2025?
    NOK 140.0m in the company and NOK 435.3m in the group. § 06
  • Who can sign for DR.DROPIN AS?
    Daglig leder og styrets leder i fellesskap. § 08
  • Who is the auditor?
    ERNST & YOUNG AS, from 25 Apr 2019. § 07
  • Where is DR.DROPIN AS based?
    Sørkedalsveien 8A, 0369 Oslo.
  • When was DR.DROPIN AS founded?
    17 May 2017, registered in the Register of Business Enterprises 19 Jun 2017. § 16

The answers come from the sections linked to, with their sources.

01Latest changesOverviewContentsClose